Announcement on Provision for Asset Impairment for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Provision for Asset Impairment for 2025
Filed with SSE ·
6ix hasn’t read this filing yet.
Shanghai Haohai Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Haohai Biological Technology
- Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Shareholding Reduction Plan for Shareholders
- Indicative Announcement on Cancellation of Repurchased H-shares and the Passive Equity Change of Controlling Shareholder, Actual Controller and Its Persons Acting in Concert Reaching 1% Scale
- Announcement on Receipt of the Decision for Administrative Penalty by One of the Company’s Controlling Shareholders and Actual Controllers Due to Non-company-related Matters
Later from Shanghai Haohai Biological Technology
- Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Multifocal Aspherical Intraocular Lens Product Obtaining the Medical Device Registration Certificate
- Report for Q1 2026
- Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Result of Shareholding Reduction by Shareholder
Follow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Haohai Biological Technology